powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1942629324
Rebecca Yarborough
M.D.
Hematology-Oncology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
93
By payment type
Food and Beverage
$2K
Long term medical supply or device loan
$1K
Top paying entities
Food and Beverage
$2K
Long term medical supply or device loan
$1K
PRESCRIBING · PART D · 2024
Total Rx claims
982
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
34
Brand share
39.8%
Top prescribed drugs
Anastrozole
137 claims
Hydrocodone/Acetaminophen
91 claims
Ondansetron
82 claims
Apixaban
54 claims
Dexamethasone
52 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
614
Unique beneficiaries
—
Total services
2,002
Distinct HCPCS
22
Medicare payment
$58K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — above median (cohort median 2,625).
